Cargando…
Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324105/ http://dx.doi.org/10.1016/j.hlc.2021.06.048 |
_version_ | 1783731354083524608 |
---|---|
author | Khattak, Z. Vlachadis Castles, A. |
author_facet | Khattak, Z. Vlachadis Castles, A. |
author_sort | Khattak, Z. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8324105 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83241052021-08-02 Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic Khattak, Z. Vlachadis Castles, A. Heart Lung Circ Article Published by Elsevier Ltd. 2021 2021-07-30 /pmc/articles/PMC8324105/ http://dx.doi.org/10.1016/j.hlc.2021.06.048 Text en Copyright © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Khattak, Z. Vlachadis Castles, A. Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic |
title | Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic |
title_full | Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic |
title_fullStr | Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic |
title_full_unstemmed | Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic |
title_short | Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic |
title_sort | prescription of angiotensin converting enzyme inhibitors and angiotensin receptor blocking agents in australia during the covid-19 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324105/ http://dx.doi.org/10.1016/j.hlc.2021.06.048 |
work_keys_str_mv | AT khattakz prescriptionofangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockingagentsinaustraliaduringthecovid19pandemic AT vlachadiscastlesa prescriptionofangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockingagentsinaustraliaduringthecovid19pandemic |